PMC:6864571 / 4029-4378 JSONTXT

{"project":"testtesttest","denotations":[{"id":"T3","span":{"begin":78,"end":83},"obj":"Body_part"},{"id":"T4","span":{"begin":201,"end":206},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"Conclusion:\nWhole-exome sequencing and EP are the most cost-effective genetic tests for epilepsy. Our analyses support for a broad population of patients with unexplained epilepsy, starting with these tests. Although less expensive, CMA has lower yield, and its use as the first-tier test is thus not supported from a cost-effectiveness perspective."}